Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-(2',4',5'-triethoxybenzoyl)propionic Acid
2. 3-(2',4',5'-triethoxybenzoyl)propionic Acid, Sodium Salt
3. Aa 149
1. 41826-92-0
2. Supacal
3. 4-oxo-4-(2,4,5-triethoxyphenyl)butanoic Acid
4. Aa 149; Supacal
5. Colibil
6. 3-(2',4',5'-triethoxybenzoyl)propionic Acid
7. H1187lu49q
8. Ncgc00167448-01
9. Dsstox_cid_26634
10. Dsstox_rid_81781
11. Dsstox_gsid_46634
12. Trepibuton
13. Trepibutonum
14. Triethoxybenzoylpropionate
15. Trepibutone [inn:jan]
16. Trepibuton [inn-spanish]
17. Trepibutonum [inn-latin]
18. Cas-41826-92-0
19. 3-(2,4,5-triethoxybenzoyl)propionic Acid
20. Aa149
21. Brn 2059640
22. Choliatron
23. Unii-h1187lu49q
24. Trepibutone ,(s)
25. Supacal (tn)
26. 2,4,5-triethoxy-gamma-oxobenzenebutanoic Acid
27. Trepibutone [mi]
28. Trepibutone [inn]
29. Trepibutone [jan]
30. Propionic Acid, 3-(2,4,5-triethoxybenzoyl)-
31. Trepibutone (jp17/inn)
32. Trepibutone [mart.]
33. Schembl25039
34. Trepibutone [who-dd]
35. Zinc2208
36. Chembl1725880
37. Dtxsid6046634
38. Chebi:32255
39. Bcp13812
40. Tox21_112452
41. Aa-149
42. Akos015896171
43. Tox21_112452_1
44. Db13311
45. Ncgc00167448-02
46. 3-(2,4,5-triethoxybenzoyl)propionicacid
47. Bs-52034
48. Hy-108283
49. Cs-0028138
50. 4-oxo-4-(2,4,5-triethoxyphenyl)butanoicacid
51. Aa149; Aa 149; Aa-149
52. D01365
53. F74234
54. 3-(2',4',5'-triethoxybenzoyl)-propionic Acid
55. 826t920
56. Q7838676
| Molecular Weight | 310.34 g/mol |
|---|---|
| Molecular Formula | C16H22O6 |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 10 |
| Exact Mass | 310.14163842 g/mol |
| Monoisotopic Mass | 310.14163842 g/mol |
| Topological Polar Surface Area | 82.1 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 357 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
A - Alimentary tract and metabolism
A03 - Drugs for functional gastrointestinal disorders
A03A - Drugs for functional gastrointestinal disorders
A03AX - Other drugs for functional gastrointestinal disorders
A03AX09 - Trepibutone
ABOUT THIS PAGE
A Trepibutone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trepibutone, including repackagers and relabelers. The FDA regulates Trepibutone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trepibutone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trepibutone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trepibutone supplier is an individual or a company that provides Trepibutone active pharmaceutical ingredient (API) or Trepibutone finished formulations upon request. The Trepibutone suppliers may include Trepibutone API manufacturers, exporters, distributors and traders.
click here to find a list of Trepibutone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Trepibutone Drug Master File in Japan (Trepibutone JDMF) empowers Trepibutone API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Trepibutone JDMF during the approval evaluation for pharmaceutical products. At the time of Trepibutone JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Trepibutone suppliers with JDMF on PharmaCompass.
Trepibutone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trepibutone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trepibutone GMP manufacturer or Trepibutone GMP API supplier for your needs.
A Trepibutone CoA (Certificate of Analysis) is a formal document that attests to Trepibutone's compliance with Trepibutone specifications and serves as a tool for batch-level quality control.
Trepibutone CoA mostly includes findings from lab analyses of a specific batch. For each Trepibutone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trepibutone may be tested according to a variety of international standards, such as European Pharmacopoeia (Trepibutone EP), Trepibutone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trepibutone USP).
LOOKING FOR A SUPPLIER?
